The Health Resources and Services Administration will pay health care providers who administer authorized COVID-19 vaccines to patients in health plans that do not cover vaccine administration or cover it with patient cost-sharing, the Department of Health and Human Services announced today. The COVID-19 Coverage Assistance Fund will reimburse providers at the national Medicare rate for vaccine administration and related patient charges for eligible claims dated on or after Dec. 14, 2020, subject to available funding through the Provider Relief Fund. The Centers for Medicare & Medicaid Services last month nearly doubled what it pays to administer COVID-19 vaccines to about $40 per dose to better reflect the costs involved and help providers vaccinate more Americans. 

“On top of increasing reimbursement rates tied to administering the shots, we are closing the final payment gap that resulted as vaccines were administered to underinsured individuals,” said HHS Secretary Xavier Becerra. “No healthcare provider should hesitate to deliver these critical vaccines to patients over reimbursement cost concerns.”
 

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…